NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 149 filers reported holding NEOGENOMICS INC in Q2 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,175,621 | -57.5% | 502,083 | +66.7% | 0.01% | -44.4% |
| Q3 2021 | $14,531,000 | -30.6% | 301,226 | -35.0% | 0.01% | -35.7% |
| Q2 2021 | $20,925,000 | -9.2% | 463,244 | -3.0% | 0.01% | -17.6% |
| Q1 2021 | $23,043,000 | -20.8% | 477,766 | -11.6% | 0.02% | -19.0% |
| Q4 2020 | $29,089,000 | +93.4% | 540,282 | +32.5% | 0.02% | +75.0% |
| Q3 2020 | $15,044,000 | +22.7% | 407,812 | +3.1% | 0.01% | +9.1% |
| Q2 2020 | $12,259,000 | +1362.9% | 395,699 | +1203.9% | 0.01% | +1000.0% |
| Q1 2020 | $838,000 | -5.1% | 30,347 | -24.6% | 0.00% | 0.0% |
| Q2 2019 | $883,000 | +8.2% | 40,260 | +1.0% | 0.00% | 0.0% |
| Q1 2019 | $816,000 | +36.0% | 39,879 | -16.2% | 0.00% | 0.0% |
| Q4 2018 | $600,000 | -9.5% | 47,578 | +10.2% | 0.00% | 0.0% |
| Q3 2018 | $663,000 | +15.7% | 43,163 | -1.3% | 0.00% | 0.0% |
| Q2 2018 | $573,000 | +90.4% | 43,736 | +18.7% | 0.00% | – |
| Q1 2018 | $301,000 | – | 36,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |